The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic Review
Abstract
Introduction: Idiosyncratic drug-induced liver injury (DILI) is a rare adverse reaction to drugs and other xenobiotics. DILI has different grades of severity and may lead to acute liver failure (ALF), for which there is no effective therapy. N-acetylcysteine (NAC) has been occasionally tested for the treatment of non-acetaminophen drug-induced ALF. However, limited evidence for its efficacy and safety is currently available. Our aim was to elucidate the benefit and safety of NAC in DILI and evaluate its hepatoprotective effect. Methods: We conducted a systematic review to evaluate the management and prevention focused on NAC in idiosyncratic DILI. The main outcomes included mortality due to DILI, time to normalization of liver biochemistry, transplant-free survival, and adverse events. We included clinical trials and observational studies, either prospective or retrospective. Results: A total of 11 studies were included after literature screening. All studies had different methodologies, and some of them had important risk of bias that may lead to interpreting their findings with caution. The majority of the studies proved NAC efficacy in a cohort of patients with ALF due to different etiologies, where DILI represented a subgroup. NAC seemed to improve transplant-free survival; however, its benefit was inconclusive in terms of overall survival. With regard to safety, NAC showed an adequate safety profile. In prevention studies, NAC showed a possible hepatoprotective effect; however, this finding is limited by the lack of studies and presence of bias. Conclusion: NAC treatment seems to have some benefit in non-acetaminophen drug-induced liver failure patients with acceptable safety; however, due to the lack of evidence and limitations detected across studies, its benefit must be corroborated in clinical trials with adequate methodology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A systematic review of 11 studies found similar improvement in transplant-free survival but inconsistent benefit in overall survival.”
From The contemporary epidemiology, causes, and management of drug-induced liver injury (2026) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Rayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Self-citationLee, W. M., Hynan, L. S., Rossaro, L., Fontana, R. J., Stravitz, R. T., Larson, A. M., Davern, T. J., Murray, N. G., McCashland, T., Reisch, J. S., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.006 · Cited by 607
Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic Failure
Harrison, P. M., Wendon, J. A., Gimson, A. E. S., Alexander, G. J. M., & Williams, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242604 · Cited by 585
Robles–Diaz, M., Lucena, M. I., Kaplowitz, N., Stephens, C., Medina–Cáliz, I., González–Jimenez, A., Ulzurrun, E., Gonzalez, A. F., Fernandez, M. C., Romero–Gómez, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.050 · Cited by 301
Self-citationCarnitine in the treatment of valproic acid-induced toxicity
Lheureux, P. E. R., & Hantson, P. (2009) · Clinical Toxicology · doi:10.1080/15563650902752376 · Cited by 274
Bateman, D. N., Dear, J. W., Thanacoody, H. K. R., Thomas, S. H. L., Eddleston, M., Sandilands, E. A., Coyle, J., Cooper, J. G., Rodriguez, A., Butcher, I., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62062-0 · Cited by 239
Interventions for paracetamol (acetaminophen) overdose
Brok, J., Buckley, N., & Gluud, C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003328.pub2 · Cited by 228
Effect of l -carnitine treatment for valproate-induced hepatotoxicity
Bohan, T. P., Helton, E., McDonald, I., König, S., Gazitt, S., Sugimoto, T., Scheffner, D., Cusmano, L., Li, S., & Koch, G. (2001) · Neurology · doi:10.1212/wnl.56.10.1405 · Cited by 184
Interventions for paracetamol (acetaminophen) overdose
Chiew, A. L., Gluud, C., Brok, J., & Buckley, N. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003328.pub3 · Cited by 170
Nabi, T., Nabi, S., Rafiq, N., & Shah, A. (2017) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.207711 · Cited by 109
Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity
Baniasadi, S., Eftekhari, P., Tabarsi, P., Fahimi, F., Raoufy, M. R., Masjedi, M. R., & Velayati, A. A. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32833aa11b · Cited by 106
Mumtaz, K., Azam, Z., Hamid, S. S., Abid, S., Memon, S., Shah, H. A., & Jafri, W. (2009) · Hepatology International · doi:10.1007/s12072-009-9151-0 · Cited by 101
Hu, J., Zhang, Q., Ren, X., Sun, Z., & Quan, Q. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.01.003 · Cited by 96
Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver Injury
Wree, A., Dechêne, A., Herzer, K., Hilgard, P., Syn, W.-K., Gerken, G., & Canbay, A. (2011) · Digestion · doi:10.1159/000322298 · Cited by 93
Drug‐Induced Liver Injury: Clinical Evidence of N‐Acetyl Cysteine Protective Effects
Ntamo, Y., Ziqubu, K., Chellan, N., Nkambule, B. B., Nyambuya, T. M., Mazibuko-Mbeje, S. E., Gabuza, K., Marcheggiani, F., Tiano, L., & Dludla, P. V. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3320325 · Cited by 79
Stravitz, R. T., Sanyal, A. J., REISCH, J. S., Bajaj, J. S., Mirshahi, F., Cheng, J., Lee, W. M., & The Acute Liver Failure Study Group (2013) · Liver International · doi:10.1111/liv.12214 · Cited by 76
Darweesh, S. K., Ibrahim, M. F., & Eltahawy, M. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0505-4 · Cited by 63
The Acute Liver Failure Study Group, Singh, S., Hynan, L. S., & Lee, W. M. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2512-x · Cited by 60
Niu, H., Sanabria-Cabrera, J., Alvarez-Alvarez, I., Robles-Diaz, M., Stankevičiūtė, S., Aithal, G. P., Björnsson, E. S., Andrade, R. J., & Lucena, M. I. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105404 · Cited by 58
Self-citationWalayat, S. (2021) · Annals of Gastroenterology · doi:10.20524/aog.2021.0571 · Cited by 58
Case Report: Terbinafine-Induced Prolonged Cholestasis with Reduction of Interlobular Bile Ducts
Mallat, A., Zafrani, É. S., Métreau, J., & Dhumeaux, D. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018870828038 · Cited by 53
Moosa, M. S., Maartens, G., Gunter, H., Allie, S., Chughlay, M. F., Setshedi, M., Wasserman, S., Stead, D. F., Hickman, N., Stewart, A., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1255 · Cited by 46
Katsinelos, P., Vasiliadis, T., Xiarchos, P., Patakiouta, F., Christodoulou, K., Pilpilidis, I., & Eugenidis, N. (2000) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200012030-00017 · Cited by 44
Shrestha, D. B., Budhathoki, P., Sedhai, Y. R., Adhikari, A. R., Poudel, A., Aryal, B. B., & Baniya, R. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100340 · Cited by 30
Borlak, J. T., van Bömmel, F., & Berg, T. (2017) · Liver International · doi:10.1111/liv.13538 · Cited by 29
The 22nd Conference of the Asian Pacific Association for the Study of the Liver
Wong, D., Seto, W., Fung, J., Ip, P. P. C., Yuen, J., Hung, I., Lai, C., & Yuen, R. (2012) · Hepatology International · doi:10.1007/s12072-011-9333-4 · Cited by 8
Impact of Duration of N-Acetylcysteine in Non-Acetaminophen–Induced Acute Liver Failure
Bass, S. N., Lumpkin, M., Mireles‐Cabodevila, E., Lindenmeyer, C. C., Dolan, B., Pickett, C., & Kapoor, A. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000411 · Cited by 5
Diaz, H. T., Serrano, R., Bowling, J. E., Anstead, G. M., & Javeri, H. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy210.809 · Cited by 3
Ahmed, S., & Rao, N. A. (2020) · Tuberculosis · doi:10.1183/13993003.congress-2020.5301 · Cited by 3
Cited by
Drug-induced liver injury: a comprehensive review
Hosack, T., Damry, D., & Biswas, S. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231163410 · Cited by 214
Björnsson, E. S., Stephens, C., Atallah, E., Robles‐Diaz, M., Alvarez‐Alvarez, I., Gerbes, A., Weber, S., Stirnimann, G., Kullak‐Ublick, G., Cortez‐Pinto, H., et al. (2023) · Liver International · doi:10.1111/liv.15378 · Cited by 69
Self-citationThe contemporary epidemiology, causes, and management of drug-induced liver injury
Swanson, L., & Fontana, R. J. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000001011
Metadata
- Authors
- Sanabria-Cabrera, J., Tabbai, S., Niu, H., Alvarez-Alvarez, I., Licata, A., Björnsson, E., Andrade, R. J., & Lucena, M. I.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2022-05-17
- Volume
- 13
- ISSN
- 1663-9812
- PMC
- PMC9152180
- Cited by
- 54
- References
- 31
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
